DK1649287T3 - Evaluering af vacciner med adjuvans - Google Patents
Evaluering af vacciner med adjuvansInfo
- Publication number
- DK1649287T3 DK1649287T3 DK04739011T DK04739011T DK1649287T3 DK 1649287 T3 DK1649287 T3 DK 1649287T3 DK 04739011 T DK04739011 T DK 04739011T DK 04739011 T DK04739011 T DK 04739011T DK 1649287 T3 DK1649287 T3 DK 1649287T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- solid phase
- immunological activity
- mixture
- activity
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49302003P | 2003-08-05 | 2003-08-05 | |
DKPA200301130 | 2003-08-05 | ||
PCT/DK2004/000514 WO2005022157A1 (en) | 2003-08-05 | 2004-07-28 | Evaluation of adjuvanted vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1649287T3 true DK1649287T3 (da) | 2008-11-24 |
Family
ID=34276701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04739011T DK1649287T3 (da) | 2003-08-05 | 2004-07-28 | Evaluering af vacciner med adjuvans |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1649287B1 (de) |
KR (1) | KR101132439B1 (de) |
CN (1) | CN1829917B (de) |
AT (1) | ATE403867T1 (de) |
AU (1) | AU2004269076B2 (de) |
CA (1) | CA2532726C (de) |
DE (1) | DE602004015611D1 (de) |
DK (1) | DK1649287T3 (de) |
ES (1) | ES2310732T3 (de) |
HK (1) | HK1094036A1 (de) |
MX (1) | MXPA06001382A (de) |
PL (1) | PL1649287T3 (de) |
WO (1) | WO2005022157A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1931998T3 (pl) | 2005-09-15 | 2010-11-30 | Alk Abello As | Sposób ilościowego oznaczania alergenów |
CA2629923C (en) * | 2005-11-24 | 2014-10-14 | Alk-Abello A/S | A method of measuring enzymatic activity of adsorbed allergenic enzyme |
BRPI0618972A2 (pt) * | 2005-11-24 | 2011-09-20 | Alk Abello As | Métodos de medição da atividade imunológica e para quantificação da quantidade de enzima alergênica em uma preparação de vacina |
GB0601058D0 (en) * | 2006-01-19 | 2006-03-01 | Univ Southampton | Mast Cell Carboxypeptidase As A Marker For Anaphylaxis And Mastocytosis |
WO2012082914A1 (en) | 2010-12-14 | 2012-06-21 | Novartis Ag | Flow cytometry analysis of materials adsorbed to metal salts |
WO2013046226A2 (en) * | 2011-08-04 | 2013-04-04 | Serum Institute Of India Ltd. | A novel quantification method for vaccines |
CN109752560A (zh) * | 2019-02-28 | 2019-05-14 | 艾棣维欣(苏州)生物制药有限公司 | 一种佐剂生物活性的检测方法 |
CN113009052A (zh) * | 2021-02-22 | 2021-06-22 | 中国食品药品检定研究院 | 水痘减毒活疫苗中β-内酰胺类抗生素的检测方法 |
EP4387594A1 (de) * | 2021-08-17 | 2024-06-26 | Innovar Scientific, Inc. | Verfahren und systeme zur bewertung und konformitätsprüfung von impfstoffen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK140815B (da) | 1975-06-10 | 1979-11-19 | Weeke Bengt | Fremgangsmåde til påvisning eller bestemmelse af antistoffer i legemsvæsker ved hjælp af kendte antigener eller til bestemmelse af antigener ved hjælp af kendte antistoffer fra legemsvæsker samt et middel til anvendelse ved udøvelse af fremgangsmåden. |
SU1746318A1 (ru) * | 1990-06-05 | 1992-07-07 | Институт полиомиелита и вирусных энцефалитов | Способ определени концентрации белка Е вируса клещевого энцефалита в препаратах вакцины, сорбированных на гидроокиси алюмини |
CN1276093C (zh) * | 2001-05-15 | 2006-09-20 | 李卫云 | 一种检测丙肝病毒RdRp酶的方法,和载体以及用其转化的细胞株及应用 |
-
2004
- 2004-07-28 CA CA2532726A patent/CA2532726C/en not_active Expired - Fee Related
- 2004-07-28 MX MXPA06001382A patent/MXPA06001382A/es active IP Right Grant
- 2004-07-28 CN CN2004800218928A patent/CN1829917B/zh not_active Expired - Fee Related
- 2004-07-28 DK DK04739011T patent/DK1649287T3/da active
- 2004-07-28 AU AU2004269076A patent/AU2004269076B2/en not_active Ceased
- 2004-07-28 ES ES04739011T patent/ES2310732T3/es not_active Expired - Lifetime
- 2004-07-28 EP EP04739011A patent/EP1649287B1/de not_active Revoked
- 2004-07-28 DE DE602004015611T patent/DE602004015611D1/de not_active Expired - Lifetime
- 2004-07-28 KR KR1020067002407A patent/KR101132439B1/ko not_active IP Right Cessation
- 2004-07-28 WO PCT/DK2004/000514 patent/WO2005022157A1/en active IP Right Grant
- 2004-07-28 AT AT04739011T patent/ATE403867T1/de active
- 2004-07-28 PL PL04739011T patent/PL1649287T3/pl unknown
-
2007
- 2007-01-10 HK HK07100314.2A patent/HK1094036A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2005022157A1 (en) | 2005-03-10 |
CN1829917B (zh) | 2010-08-25 |
KR20060126892A (ko) | 2006-12-11 |
PL1649287T3 (pl) | 2009-04-30 |
CA2532726A1 (en) | 2005-03-10 |
ATE403867T1 (de) | 2008-08-15 |
EP1649287B1 (de) | 2008-08-06 |
ES2310732T3 (es) | 2009-01-16 |
EP1649287A1 (de) | 2006-04-26 |
HK1094036A1 (en) | 2007-03-16 |
AU2004269076B2 (en) | 2007-09-20 |
AU2004269076A1 (en) | 2005-03-10 |
CA2532726C (en) | 2013-03-12 |
DE602004015611D1 (de) | 2008-09-18 |
KR101132439B1 (ko) | 2012-03-30 |
CN1829917A (zh) | 2006-09-06 |
MXPA06001382A (es) | 2006-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1094036A1 (en) | Evaluation of adjuvanted vaccines | |
CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
HUP0500444A2 (hu) | HCV antigén/ellenanyag-kombinációs esszé | |
ATE188487T1 (de) | Anti-gp39 antikoerper und deren verwendungen | |
HUP0303134A3 (en) | Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv | |
DK1157042T3 (da) | Fremstilling af tetravalente antistoffer | |
CY1114047T1 (el) | Νεοι φορεις εκφρασης και χρησεις αυτων | |
ATE556717T1 (de) | Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus | |
WO2005078450A3 (en) | Method for the detection of early b cell populations in vaccine development | |
DE60331677D1 (de) | Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper | |
MX2007000916A (es) | Anticuerpo enriquecido para detectar infeccion micobacteriana, metodos de uso y prueba de diagnostico que emplea la misma. | |
ES2176347T3 (es) | Modulacion de la respuesta inmune. | |
DE60129278D1 (de) | Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen | |
ID20581A (id) | Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen | |
WO2004102198A3 (en) | Selection of b cells with specificity of interest: method of preparation and use | |
WO2003046140A3 (en) | Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample | |
ATE445839T1 (de) | Latentes tuberkulose-diagnostisches antigen und verwendungsmethode | |
BR0011449A (pt) | Método para detectar sìfilis usando antìgenos sintéticos | |
ATE530572T1 (de) | Antigen-cocktails, p35 und verwendungen dafür | |
CA2350340A1 (en) | B-cell epitopes of hsp65 and uses thereof | |
WO2004032599A3 (en) | Novel immunogenic proteins of leptospira | |
RU2006112203A (ru) | Экспресс-тест для диагностирования болезни альцгеймера | |
FR2829767A1 (fr) | Composes peptidiques destines a la prevention et au traitement d'affections chez les mammiferes | |
DE69937258D1 (de) | Genetische impstoffe mit adjuvans | |
Haaheim et al. | Antibodies from lymphocytes used as diagnostic markers: a novel approach |